Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC)
Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prove the therapeutic equivalence and safety of once-daily 9
mg budesonide versus 3 g mesalazine in a 8-week treatment in patients with active ulcerative
colitis.